---  
layout: startup_page  
title: "GenrAb"  
id: "genrab.com"  
permalink: "/genrabgenrab.com04222025/"  
website: "https://www.genrab.com/"  
funding_round: "Seed"  
funding_amount: "$5.6M"  
investors: "Actium Group, Salem Partners, GPG Ventures, Research Bridge Partners, Maytal Capital"  
about: "GenrAb, Inc. develops first-in-class neuroprotective therapies using a unique approach of identifying naturally occurring, human neuroprotective antibodies from the cerebrospinal fluid of patients with neurological diseases. Their lead candidate, TGM-010, is a fully-human antibody designed to cross the blood-brain barrier and reduce neurological disability. GenrAb aims to create high-impact medicines to address the significant unmet needs in neurodegenerative disease treatment."  
markets: "Biotechnology, Therapeutics"  
hq: "Dallas, Texas, United States"  
founded_year: "2022"  
linkedin: ""  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/genrab"  
pitchbook: "https://pitchbook.com/profiles/company/638189-65"  

date_display: "22-Apr-2025"  
date: "2025-04-22"

# SEO Optimization  
meta_title: "GenrAb - Seed Funding ($5.6M)"  
meta_description: "GenrAb, GenrAb, Inc. develops first-in-class neuroprotective therapies using a unique approach of identifying naturally occurring, human neuroprotective antib..."  
meta_keywords: "GenrAb, Biotechnology, Therapeutics, Seed funding"  
canonical_url: "https://startup.projectstartups.com/genrabgenrab.com04222025/"  
---